Science and Progress at the FDA:Realizing the Return on Investment from Biomedical Research Briefing- Invite

March 17, 2010

PDF:

Realizing the Return on Investment from Biomedical Research Briefing- Invite

A discussion on why increased scientific capacity at the FDA is what will ensure patients and their families can access and benefit from the latest scientific breakthroughs.

Wednesday, March 24, 2010

11:00am-12:00pm

Room H137 in the U.S. Capitol

Science and Progress at the FDA:Realizing the Return on Investment from Biomedical Research Briefing- Invite

Inside Health Policy — Public Citizen Lays Out Legal Arguments For FDA Keeping LDT Role

Patient, Research and Provider Groups File Amicus Brief Supporting FDA’s Rule on Laboratory Developed Test Regulation

Science and Progress at the FDA:Realizing the Return on Investment from Biomedical Research Briefing- Invite

Read More

Inside Health Policy — Public Citizen Lays Out Legal Arguments For FDA Keeping LDT Role

Patient, Research and Provider Groups File Amicus Brief Supporting FDA’s Rule on Laboratory Developed Test Regulation